CLC Number:
| [1] 吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2009: 1020. [2] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917. [3] Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States[J]. J Invest Dermatol, 2009,129(7): 1666-1674. [4] Azoury SC,Lange JR. Epidemiolgy, risk factors, prevention, and early detection of melanoma[J]. Surg Clin North Am, 2014, 94(5): 1066. [5] Mathew R, Messina JL. Recent advances in pathologic evaluation and reporting of melanoma[J]. Semin Oncol, 2012, 39(2): 184-191. [6] Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from a generation of a probabilistic model[J]. Ann Surg Oncol, 2004, 11(3): 247-258. [7] Gouley A. Melanoma staging.Mitotic rate now recognized as the most powerful predictor[J]. Adv NPs Pas, 2013, 4(5): 31-32. [8] Patrick C, Walsh. Alan B, Ratik, et al. Campbells urology seventh edtion[M]. 北京:科学出版社,2001: 2478. [9] Sanchez-Ortiz R, Huang SF, Tambolip, et al. Melanoma of the penis acrotum and male urethra: a 40-year sengle institution experience[J]. J Urol, 2005, 173(6): 1958-1965. [10] Kauffmann RM, Chen SL. Workup and staging of malignant melanoma[J]. Surg Clin North Am, 2014, 94(5): 965-972. |
| No related articles found! |
|
||
